RESOURCES
News
Cancer Today Spotlights Lynx Dx’s MPS2 as a Breakthrough At-Home Prostate Cancer Test
In a recent feature, Cancer Today explores how MyProstateScore 2.0 (MPS2) may help men avoid unnecessary or [...]
Lynx Dx Launches Ordering for At-Home Collection Version of MyProstateScore 2.0
MyProstateScore 2.0 (MPS2) will be made available for at-home sample collection.
Lynx Dx Introduces At-Home Collection Option for MyProstateScore 2.0
MyProstateScore 2.0 (MPS2) will be made available for at-home sample collection.
Lynx Dx Wins Award as One of ’50 Companies to Watch’ by Michigan Celebrates Small Business
ANN ARBOR, Mich.– Lynx Dx, a leader in innovative diagnostic solutions, has been recognized as one [...]
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer
Lynx Dx's Biomarker Test Offers Market-Leading Accuracy in Prostate Cancer Risk Assessment ANN ARBOR, Mich., April [...]
Lynx Dx Relocates to New and Improved Headquarters to Prime Next Phase of Growth
ANN ARBOR, MI – Lynx Dx, an Ann Arbor-based genomics startup and developer of the revolutionary MyProstateScore [...]
Lynx Dx, Inc.’s Laboratory Receives Accreditation from the College of American Pathologists
ANN ARBOR, MI – The Accreditation Committee of the College of American Pathologists (CAP) awarded accreditation to [...]
Lynx Dx, Inc. Website Wins Gold in 25th Anniversary Digital Health Awards®
ANN ARBOR, MI – Lynx Dx,Inc. was selected as a winner in the 25th anniversary Digital [...]
Lynx Dx President Steve Riggs Named Finalist for the Entrepreneur Of The Year® 2023 Michigan and Northwest Ohio
Entrepreneur Of The Year celebrates ambitious entrepreneurs who are building bolder futuresANN ARBOR, MI – Lynx Dx, [...]